Discover Digital Health Startups in Nanjing

12 Digital Health ventures are based in Nanjing. The total venture volume has expanded at a CAGR of 1.8% over the past 5 years. The ventures have an average venture maturity score of 54.9.

In total, $350.76M of Digital Health venture capital has been raised across 24 funding deals.

Last Updated: November 18, 2023

Ventures

ShowEntries

Startup	Primary Category	Country	Therapeutic Focus	Valuation	Stage	Current Funding	Track
Singleron (新格元生物科技)	Omics Related Research	China	xyrsttzsas	$ 123.46 B	Series B	$ 100.00 M	Toggle
DiaCarta (DiaCarta帝基生物)	Omics Related Diagnosis	China	xyrsttzsas	$ 123.46 B	Grant	$ 0.04 M	Toggle
Silexon (燧坤智能)	Drug Discovery	China	xyrsttzsas	$ 123.46 B	Series A	$ 15.49 M	Toggle
mHealth365 (掌上心电)	Disease Management	China	xyrsttzsas	$ 123.46 B	Series A	$ 1.45 M	Toggle
Dajing TCM (大经中医)	Prescriptive Analytics	China	xyrsttzsas	$ 123.46 B	Series A1	undisclosed	Toggle
Eaglenos (晶捷生物科)	Remote Diagnostic Devices	China	xyrsttzsas	$ 123.46 B	Series A	$ 21.14 M	Toggle
Tanica	Omics Related Diagnosis	China	xyrsttzsas	$ 123.46 B	Series A	$ 10.00 M	Toggle
Dr Terry (泰立瑞)	Teleconsultation	China	xyrsttzsas	$ 123.46 B	Angel	$ 0.72 M	Toggle
Xinli.ai (阿尔法心理)	Digital Therapeutics	China	xyrsttzsas	$ 123.46 B	Seed	undisclosed	Toggle
ShenTaiWang (肾泰网)	Disease Management	China	xyrsttzsas	$ 123.46 B			Toggle

Showing 1 to 10 of 12 entries